These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

367 related articles for article (PubMed ID: 1431022)

  • 1. Potential indications for the selective serotonin reuptake inhibitors.
    Boyer WF
    Int Clin Psychopharmacol; 1992 Jun; 6 Suppl 5():5-12. PubMed ID: 1431022
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Selective serotonin-reuptake inhibitors: an update.
    Masand PS; Gupta S
    Harv Rev Psychiatry; 1999; 7(2):69-84. PubMed ID: 10471245
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Paroxetine. An update of its pharmacology and therapeutic use in depression and a review of its use in other disorders.
    Gunasekara NS; Noble S; Benfield P
    Drugs; 1998 Jan; 55(1):85-120. PubMed ID: 9463792
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Selective serotonin reuptake inhibitors and tricyclic antidepressants in combination. Interactions and therapeutic uses.
    Taylor D
    Br J Psychiatry; 1995 Nov; 167(5):575-80. PubMed ID: 8564311
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Selective serotonin reuptake inhibitors: pharmacologic profiles and potential therapeutic distinctions.
    Finley PR
    Ann Pharmacother; 1994 Dec; 28(12):1359-69. PubMed ID: 7696728
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Selective serotonin reuptake inhibitor(SSRI)].
    Motohashi N
    Nihon Rinsho; 2001 Aug; 59(8):1519-22. PubMed ID: 11519151
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Selective serotonin reuptake inhibitors (SSRIs) and serotonin-norepinephrine reuptake inhibitors (SNRIs) for the prevention of tension-type headache in adults.
    Banzi R; Cusi C; Randazzo C; Sterzi R; Tedesco D; Moja L
    Cochrane Database Syst Rev; 2015 May; 2015(5):CD011681. PubMed ID: 25931277
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Therapy with selective serotonin reuptake inhibitors (SSRI). Indications, uses and risks].
    Ebert D
    Fortschr Med; 1996 Jul; 114(18-19):243-7. PubMed ID: 8766793
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparative efficacy of antidepressants.
    Kasper S; Fuger J; Möller HJ
    Drugs; 1992; 43 Suppl 2():11-22; discussion 22-3. PubMed ID: 1378369
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Efficacy of selective serotonin reuptake inhibitor treatment in children and adolescents].
    Bailly D
    Presse Med; 2006 Sep; 35(9 Pt 2):1293-302. PubMed ID: 16969324
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Selective serotonin reuptake inhibitors (SSRIs): therapeutic drug monitoring and pharmacological interactions.
    Mandrioli R; Mercolini L; Saracino MA; Raggi MA
    Curr Med Chem; 2012; 19(12):1846-63. PubMed ID: 22414078
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Selective serotonin reuptake inhibitors in the treatment of paediatric anxiety disorders: a review.
    Murphy TK; Bengtson MA; Tan JY; Carbonell E; Levin GM
    Int Clin Psychopharmacol; 2000 Aug; 15 Suppl 2():S47-63. PubMed ID: 11110019
    [TBL] [Abstract][Full Text] [Related]  

  • 13. New indications for antidepressants.
    Schatzberg AF
    J Clin Psychiatry; 2000; 61 Suppl 11():9-17. PubMed ID: 10926050
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Developments in the drug treatment of panic disorder: what is the place of the selective serotonin reuptake inhibitors?
    Westenberg HG
    J Affect Disord; 1996 Sep; 40(1-2):85-93. PubMed ID: 8882918
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Paroxetine, sertraline, and fluvoxamine: new selective serotonin reuptake inhibitors.
    Grimsley SR; Jann MW
    Clin Pharm; 1992 Nov; 11(11):930-57. PubMed ID: 1464219
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Use of serotonin selective reuptake inhibitors in geriatric depression.
    Newhouse PA
    J Clin Psychiatry; 1996; 57 Suppl 5():12-22. PubMed ID: 8647788
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Fluvoxamine in the treatment of depressive disorders in alcohol dependence: results of randomized open-label comparative study].
    Vinnikova MA; Severtsev VV; Komarov SD; Vdovin AS
    Zh Nevrol Psikhiatr Im S S Korsakova; 2021; 121(12):57-62. PubMed ID: 35041313
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Switching Selective Serotonin Reuptake Inhibitors in Adolescents with Selective Serotonin Reuptake Inhibitor-Resistant Major Depressive Disorder: Balancing Tolerability and Efficacy.
    Strawn JR; Mills JA; Croarkin PE
    J Child Adolesc Psychopharmacol; 2019 May; 29(4):250-255. PubMed ID: 30810350
    [No Abstract]   [Full Text] [Related]  

  • 19. [Differential features of SSRIs].
    Cervera S
    Rev Med Univ Navarra; 1997; 41(4):245-57. PubMed ID: 10420965
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Serotonin selective reuptake inhibitors in child and adolescent psychopharmacology: a review of published experience.
    DeVane CL; Sallee FR
    J Clin Psychiatry; 1996 Feb; 57(2):55-66. PubMed ID: 8591970
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.